US President Trump has announced that new tariffs on pharmaceuticals will be introduced soon, creating uncertainty for India's drug makers. Industry insiders are considering alternative markets to offset potential impacts, with companies preparing for any eventual developments.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/T6McNyK
via IFTTT
-
Kotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient...
-
Vaccine manufacturer Serum Institute of India (SSI) has filed a challenge to the Supreme Court against a 2016 amendment to the Income Tax Ac...
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2025
(227)
-
▼
April
(27)
- Weight is over! Pharma companies race to make weig...
- USFDA issues Form 483 with 11 observations to Rale...
- Morepen to hire 1,000 medical representatives to s...
- Cipla gets USFDA nod for generic cancer drug
- Tariff risks cloud near-term pharma deals outlook:...
- US court lifts restrictions on Sun Pharma launchin...
- Natco to sell rare spinal disease drug Risdiplam f...
- ZIM Labs inks pact with Globalpharma Co to commerc...
- Trump signals major tariff on pharma imports, Indi...
- As Empagliflozin goes off patent, 71 copies of the...
- India's anti-obesity drug market has grown more th...
- India’s anti-obesity drug market quadruples in fiv...
- PE firms bet on small-town hospitals for a growth ...
- Sun Pharma launches medication for Erosive Esophag...
- Novo Nordisk readies to bring weight-loss drug Weg...
- Govt plans capacity building activities for frontl...
- Indians are quitting the safety net of health insu...
- Kerala launches digital payment system, online ser...
- Now Pharma Inc looks for cure as Trump delivers do...
- People Tree Hospital Secures 25 Million USD (₹220 ...
- T-Rx: Indian pharma majors breathe easy as US spar...
- 'Pharma's exemption from reciprocal tariffs unders...
- Big relief for India! Trump spares pharma from har...
- Fortis healthcare buys disputed Fortis trademark f...
- Lupin acquires UK-based firm for 12.3 million pounds
- Market volatility derails Novartis' plan to sell s...
- 360 ONE, Claypond Capital get CCI nod to acquire s...
-
▼
April
(27)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment